Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-21-002475
Filing Date
2021-06-11
Accepted
2021-06-11 14:35:41
Documents
1
Period of Report
2021-06-09

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3976
  Complete submission text file 0001683168-21-002475.txt   5439
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Issuer) CIK: 0001355790 (see all company filings)

EIN.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 OVERLOOK DR. UNIT 11 AMHERST NH 03031
Business Address
Semechkin Andrey (Reporting) CIK: 0001447708 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51891 | Film No.: 211010840